Lee, Ji MinJi MinLeeSHU-CHEN WEILee, Kang-MoonKang-MoonLeeYe, Byong DukByong DukYeMao, RenRenMaoKim, Hyun-SooHyun-SooKimPark, Soo JungSoo JungParkPark, Sang HyoungSang HyoungParkOh, Eun HyeEun HyeOhIm, Jong PilJong PilImJang, Byung IkByung IkJangKim, Dae BumDae BumKimTakeuchi, KenKenTakeuchi2022-10-062022-10-06202219762283https://scholars.lib.ntu.edu.tw/handle/123456789/623407Little is known about the clinical course of hepatitis B virus (HBV)-infected patients undergoing anti-tumor necrosis factor α (TNF-α) therapy for inflammatory bowel disease (IBD). We aimed to investigate the clinical course of HBV infection and IBD and to analyze liver dysfunction risks in patients undergoing anti-TNF-α therapy.enAnti-tumor necrosis factor alpha; Hepatitis B virus; Inflammatory bowel disease; Reactivationjournal article10.5009/gnl210081345936702-s2.0-85130635353https://api.elsevier.com/content/abstract/scopus_id/85130635353